Aging CellNeurosciencePeer-reviewed journal article
Protracted fate acquisition and epigenetic de-aging during induced neural stem cell conversion of human blood cells
Lea Jessica BergiD, Julia FranzeniD, Andreas BuneßiD, Rachel Konang, Chao ShengiD, Michael PeitziD, Andreas TilliD, Wolfgang WagneriD, Oliver BrüstleiD
Abstract
Transcription factor-based direct conversion of somatic cells represents an interesting avenue for generating induced neural stem cells (iNSCs) from peripheral blood without transit through a pluripotent stage. While this paradigm has been shown to be associated with epigenetic de-aging, the dynamics of this process have remained unclear. Here, we used overexpression of the two reprogramming factors SOX2 and cMYC to generate iNSC from erythroid progenitors of donors ranging from neonatal to 101 years of age. Using an epigenetic clock algorithm, we corroborated our previous finding that iNSCs generated from aged donors show pronounced epigenetic de-aging, preserving around 13 % and 5 % of the original donor age at low and high passages, respectively. Studying the dynamic of epigenetic de-aging during iNSC conversion across time, we found that this process is largely protracted, continuing for several weeks and even beyond forced neuronal differentiation of iNSCs. Transcriptomic differences between young and old donor-derived iNSCs dissipate with extended time in conversion, too. Concordant with this observation, established iNSC lines lack age-associated cellular hallmarks, similar to induced pluripotent stem cells and their derivatives. Interestingly, time course analysis of DNA methylation and RNA sequencing data revealed that acquisition of a bona fide NSC signature extends greatly beyond the time point when proliferative PAX6-positive iNSCs emerge. The unexpected slow dynamics of these processes makes iNSC conversion an attractive model for dissecting the mechanisms underlying somatic transdifferentiation and de-aging. Statement of Ethical ApprovalsThe collection of human somatic material (i.e., blood) from healthy donors for iPSC reprogramming and iNSC conversion was conducted in accordance with German law and approved by the Ethics Committee of the University of Bonn Medical Center (approval number: 275/08). All subjects gave written informed consent.
- organism: human
- assay: bulk RNA-seq
- assay: DNA methylation
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 32%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of DNA methylation in PBMCs and donor-matched iPSCs shows methylation is reset during stem cell reprogramming
Xylena Reed, Cory A. Weller, … Mark Cookson·bioRxiv·Dec 13, 2024
- Sustained epigenetic rejuvenation of serially engrafting human iPSC-derived HSCs
Arjun Jain, Jacky Li, … Anastasia V. Shindyapina·bioRxiv·Jul 17, 2026
- Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity
Nelly N. Olova, Daniel J. Simpson, … Tamir Chandra·Aging CellPeer-reviewed·Nov 18, 2018
- Multi-omic rejuvenation of human cells by maturation phase transient reprogramming
Diljeet Gill, Aled Parry, … Wolf Reik·eLifePeer-reviewed·Apr 7, 2022
- Transient non-integrative nuclear reprogramming promotes multifaceted reversal of aging in human cells
T. J. Sarkar, M. Quarta, … V. Sebastiano·bioRxiv·Mar 18, 2019
- Disease-associated mutations directionally modulate epigenetic age in iPSC-derived tissues
Nicholas J. Skvir, Todd W. Dowrey, … George J. Murphy·bioRxiv·Oct 4, 2026